News

Granite (NYSE:GVA) has been selected for the State Route 20 Omega Curve Realignment project in Nevada County, California. The project is awarded by Caltrans and funded by State and Federal aid. The

Guess?, Inc. (NYSE: GES) will release its financial results for the fourth quarter and fiscal year 2022, which ended January 29, 2022, on Wednesday, March 16, 2022. The Company will webcast a

The First Bancshares, Inc. (NASDAQ: FBMS) (“First Bancshares” or the “Company”), the holding company for The First Bank, announced today that the Company’s board of directors has approved a new

The Board of Directors of GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), is pleased to announce the implementation of its long-planned succession process and that, after twenty years at

GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent Latin American oil and gas explorer, operator and consolidator, announces that its Board of Directors has declared a

GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent Latin American oil and gas explorer, operator and consolidator, reports its consolidated financial results for the

McGrath RentCorp (Nasdaq:MGRC), a diversified business-to-business rental company, today announced that it will participate in the Sidoti & Company, LLC Spring Virtual Small Cap Investor Conference

First Trust Global Portfolios Management Limited (“FTGPM”) announces the declaration of the quarterly distributions for the following sub-funds of First Trust Global Funds plc.

ISIN

Fund

Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 32^nd Annual Healthcare Conference on Wednesday, March 16, 2022, at approximately 8:40

Gold Reserve Inc. (TSX.V: GRZ) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announced that it has learned that The Ministry of Mines of Bolivarian Republic of Venezuela (“Ministry of Mines”)

State Street Corporation (NYSE: STT) announced today that State Street Digital, the firm’s dedicated Digital division, has entered into a licensing agreement with Copper.co, a London-based provider

Pitney Bowes (NYSE: PBI), a global shipping and mailing company that provides technology, logistics, and financial services and Ambi Robotics, the leader in robotic sorting systems for supply chain

Regulatory News:

Philip Morris International Inc. (NYSE: PM) today announces the suspension of its planned investments in the Russian Federation, including all new product launches and

Alcoa Corporation (NYSE: AA) today officially marked the completion of a capital project that is expected to improve stability, increase efficiency, and boost production at its Deschambault

Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering upstream therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company”) (NASDAQ: IPA) (TSXV: IPA) is pleased to report on the latest progress in the development of their PolyTope® TATX-03 antibody cocktail therapy

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at Oppenheimer’s 32nd Annual

Ozon Holdings PLC (NASDAQ and MOEX: “OZON”, thereafter referred to as “we,” “us,” “our,” “Ozon” or the “Company”), a leading Russian e-commerce platform, provides further update on the potential

REV Group, Inc. (NYSE: REVG), a manufacturer of industry-leading specialty vehicles, today reported results for the three months ended January 31, 2022 (“first quarter 2022”). Consolidated net

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Tucker Kelly, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Barclays Global

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, today

Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: CRSWF) (FSE: 3XI), a leading biotech company focused on innovation and research on endogenous tryptamines (biomolecules acting

Pfizer Inc. (NYSE: PFE) announced today that it has initiated a Phase 2/3 study, EPIC-PEDS (Evaluation of Protease Inhibition for COVID-19 in Pediatric Patients), to evaluate the safety